Real World Data: Reaching beyond claims for better insight Novel approaches to conduct research using secondary data sources and methods

Register free: https://www.pharmexec.com/pe_w/insight ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Event Overview:

Real world data (RWD) now plays a pivotal role in informing decisions about access, reimbursement, and comparative effectiveness. Medical and prescription claims data represent traditional sources of secondary data used to conduct real world research, yet those sources sometimes lack key outcomes of interest, especially those focused on disease morbidity or severity. 

In this webinar, we’ll discuss two commonly used sources of clinical data in depth, which when linked with claims data, help to measure clinically rich outcomes. We will also review analytic approaches to define morbidity and mortality using claims data. Case examples will be reviewed in the clinical areas of oncology, as well as multiple sclerosis.

Key Learning Objectives:

• Evaluate clinically rich data sources including electronic medical records (EMR) and laboratory data that allow the assessment of disease severity and progression
• Review a hospital-based data source and appreciate the outcomes it captures that are generally unavailable in claims-based sources
• Understand methods to model morbidity and mortality when it is unmeasured in the data. These represent important outcomes of interest to payers

Speakers: Chi-Chang Chen, MPharm PhD, Principal, Health Economics and Outcomes Research, Real World Evidence, IQVIA

Rolin Wade, RPh, MS, Senior Principal, Health Economics and Outcomes Research, IQVIA

Time and Date: Thursday December 10, 2020 11am EST

On demand available after final airing until Dec. 10, 2021

Register free: https://www.pharmexec.com/pe_w/insight